Neonatal opioid withdrawal syndrome (NOWS) has risen in prevalence from 1.2 per 1000
births in 2000 to 5.8 per 1000 births in 2012. Symptoms in neonates may include high …

The developmental impact of opioid use during pregnancy is a subject of ongoing debate.
Short-term neonatal outcomes, such as lower birth weight and neonatal abstinence …

Importance The number of children with prenatal opioid exposure to medication for addiction
treatment (MAT) with methadone and buprenorphine for maternal opioid use disorder is …

Opioid pain reliever addiction has increased among women of reproductive age over the
last fifteen years. News media and public attention have focused on the implications of this …

Background: Infants with neonatal abstinence syndrome (NAS) experience withdrawal that
occurs as a result of termination of placental opioid supply following delivery. Common …

Neonates exposed prenatally to opioids will often develop a collection of withdrawal signs
known as neonatal abstinence syndrome (NAS). The incidence of NAS has substantially …

One consequence of the opioid epidemic are lasting neurodevelopmental sequelae
afflicting adolescents exposed to opioids in the womb. A translationally relevant and …

Objective: The objective of the study was to evaluate the association between neonatal
abstinence syndrome (NAS) and long-term childhood morbidity and infant mortality. Study …

The opioid epidemic is a rapidly evolving societal issue driven, in part, by a surge in
synthetic opioid use. A rise in fentanyl use among pregnant women has led to a 40-fold …

The incidence of neonatal opioid withdrawal syndrome (NOWS) has increased substantially
in the setting of the opioid epidemic, a major public health problem in the United States. At …